Finox Biotech

Kirchdorf, Switzerland Founded: 2007 • Age: 19 yrs Acquired By Gedeon Richter
Fertility products are developed by this Swiss biopharma firm.

About Finox Biotech

Finox Biotech is a Healthcare company based in Kirchdorf (Switzerland) founded in 2007, and was acquired by Gedeon Richter in June 2016. Fertility products are developed by this Swiss biopharma firm. Its focus areas include Life Sciences, Women Health, Drugs and Sustainability Tech.

Company details

Finox Biotech was established in 2007 in Kirchdorf, Switzerland, within the biopharma sector. Focus is placed on fertility treatments, with operations integrated into Gedeon Richter, a Hungarian multinational, since June 2016. Bemfola, a recombinant-human follicle-stimulating hormone biosimilar to Gonal-F, is distributed alongside a disposable device for patient self-injection.

  • Headquarters Kirchdorf, Switzerland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website finoxbiotech.com
  • Social LinkedIn X
  • Acquired by Gedeon Richter (Jun 2016)
Key Metrics

Investors in Finox Biotech

Finox Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Richter Gedeon.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical manufacturing, research, and marketing in Hungary.
richter.hu
Premium access

Investor details for Finox Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Finox Biotech

2 dated milestones of Finox Biotech across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Finox Biotech is founded.
  2. Exit Acquired by Gedeon Richter.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Finox Biotech

Assets successfully sold by Fertility Biotech
Startupticker β€’ 8 years ago
Premium access

Complete news archive for Finox Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Finox Biotech

Finox Biotech was founded in 2007.

Finox Biotech is headquartered in Kirchdorf, Switzerland. It is registered at Kirchdorf, Bern, Switzerland.

Finox Biotech was established in 2007 in Kirchdorf, Switzerland, within the biopharma sector. Focus is placed on fertility treatments, with operations integrated into Gedeon Richter, a Hungarian multinational, since June 2016. Bemfola, a recombinant-human follicle-stimulating hormone biosimilar to Gonal-F, is distributed alongside a disposable device for patient self-injection.

Finox Biotech has 1 investor. Key investors include Richter Gedeon.

Yes. Finox Biotech was acquired by Gedeon Richter in June 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available